{
    "2018-03-26": [
        [
            {
                "time": "",
                "original_text": "上药2017年营收1308亿 力争进入世界500强",
                "features": {
                    "keywords": [
                        "营收",
                        "1308亿",
                        "世界500强"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[买入评级] 上海医药(601607)年报点评：主业稳健增长 报表质量优秀",
                "features": {
                    "keywords": [
                        "买入评级",
                        "上海医药",
                        "年报",
                        "稳健增长",
                        "报表质量优秀"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药：报表质量优秀 买入评级",
                "features": {
                    "keywords": [
                        "上海医药",
                        "报表质量优秀",
                        "买入评级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【港股解码】国药控股(01099-HK)：两票制对行业整体利好，对股价走势有信心",
                "features": {
                    "keywords": [
                        "港股",
                        "国药控股",
                        "两票制",
                        "行业利好",
                        "股价走势信心"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒生指数收涨0.79% 石油股走强",
                "features": {
                    "keywords": [
                        "恒生指数",
                        "收涨",
                        "石油股",
                        "走强"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "港股异动︱药品股逆势走强 康哲药业(00867)现涨近7%",
                "features": {
                    "keywords": [
                        "港股",
                        "药品股",
                        "逆势走强",
                        "康哲药业",
                        "涨近7%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞、复星发力 医药板块重拾涨势",
                "features": {
                    "keywords": [
                        "恒瑞",
                        "复星",
                        "医药板块",
                        "重拾涨势"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "营收增速放缓 工业板块驱动业绩提升",
                "features": {
                    "keywords": [
                        "营收增速放缓",
                        "工业板块",
                        "业绩提升"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "工业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "上海医药（601607）2017年年报点评：工业内生提速，分销有望改善",
                "features": {
                    "keywords": [
                        "上海医药",
                        "年报",
                        "工业内生提速",
                        "分销改善"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【个股公告】今日公布重磅利好",
                "features": {
                    "keywords": [
                        "个股公告",
                        "重磅利好"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药: 核心业务增长稳健, 合营企业拖累业绩",
                "features": {
                    "keywords": [
                        "上海医药",
                        "核心业务",
                        "增长稳健",
                        "合营企业",
                        "拖累业绩"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "上海医药: 主业内生增速符合预期, 合、联营企业投资收益拉低扣非业绩",
                "features": {
                    "keywords": [
                        "上海医药",
                        "主业内生增速",
                        "符合预期",
                        "合联营企业",
                        "投资收益",
                        "拉低扣非业绩"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}